The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques. 2000

L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
Department of Virology, Biomedical Primate Research Centre, PO Box 3306, 2280 GH Rijswijk, The Netherlands.

Of the viral factors that are proposed to influence the rate of progression to AIDS, the role of infectious dose remains unresolved. Intravenous infection of outbred Macaca mulatta with various doses of simian immunodeficiency virus isolate 8980 (SIV(8980)) revealed an endpoint from which an infectious dose 50 (ID(50)) was defined. In the six infected animals, the time to develop AIDS was variable with a spectrum of rapid, intermediate and slow progressors. High and sustained plasma viraemia with marked loss of CD4(+) T-cells was a distinguishing feature between rapid versus intermediate and slow progressors. Animals that received the highest doses did not develop the highest sustained viral loads, nor did they progress more rapidly to disease. Similarly, animals infected with lower doses did not uniformly develop lower viral loads or progress more slowly to AIDS. Furthermore, compiled data from more than 21 animals infected with different doses of the same virus administered by the same route failed to reveal any correlation of infectious dose with survival. Indeed, host factors of these outbred animals, rather than dose of the initial inoculum, were probably an important factor influencing the rate of disease progression in each individual animal. Comparison of animals infected with SIV(B670), from which SIV(8980) was derived, revealed marked differences in disease progression. Clearly, although dose did not influence viral loads nor disease progression, the virulence of the initial inoculum was a major determinant of the rate of progression to AIDS.

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome

Related Publications

L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
March 2013, Journal of immunology (Baltimore, Md. : 1950),
L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
July 1995, Journal of virology,
L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
September 2017, Journal of virology,
L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
September 1992, Laboratory investigation; a journal of technical methods and pathology,
L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
December 2013, Journal of virology,
L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
December 2016, The Journal of general virology,
L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
June 2021, AIDS (London, England),
L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
November 1993, AIDS (London, England),
L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
February 2009, Journal of virology,
L Holterman, and H Niphuis, and W Koornstra, and R Dubbes, and P ten Haaft, and J L Heeney
September 2000, Veterinary pathology,
Copied contents to your clipboard!